Seeking Alpha

Seeking Alpha Portfolio App for iPad

3 people get SNUS articles and Market Currents by email alert.

Get email alerts on SNUS »

SNUS

Sonus Pharmaceuticals, Inc.

5/22/2013, 4:28 AM ET

Quote & Headlines StockTalk

SNUS is defunct.

HEADLINES:

ALL | PRO | FOCUS | RELATED | TRANSCRIPTS | NEWS & PR

SNUS

Fortress Stands Tall on Earnings
optionMONSTER • Tue, Mar 1, 2011 • 2 Comments
SNUS

Cancer Stocks Finish a Tough Quarter
Alan Brochstein • Mon, Oct 1, 2007
SNUS

Two Important Lessons to be Learned from Sonus
Brett Scott • Tue, Sep 25, 2007 • 1 Comment
SNUS

Sonus Is Undervalued At $4 - Call Options Are Attractive
Brett Scott • Thu, Aug 30, 2007
SNUS

Sonus Pharmaceuticals: Tocosol Approval Looks Promising
Mike Havrilla • Wed, Jul 11, 2007

To learn more about Seeking Alpha Pro, click here.

SNUS

Two Important Lessons to be Learned from Sonus
Brett Scott • Tue, Sep 25, 2007 • 1 Comment
SNUS

Sonus Is Undervalued At $4 - Call Options Are Attractive
Brett Scott • Thu, Aug 30, 2007
SNUS

Sonus Pharmaceuticals: Tocosol Approval Looks Promising
Mike Havrilla • Wed, Jul 11, 2007

SNUS

Fortress Stands Tall on Earnings
optionMONSTER • Tue, Mar 1, 2011 • 2 Comments
SNUS

Cancer Stocks Finish a Tough Quarter
Alan Brochstein • Mon, Oct 1, 2007

There are no Transcripts on SNUS.

There are no News articles on SNUS.

Company Description

Currently, there's no company description for SNUS.

Country: United States